FDA provided Emergency Use Authorization to PerkinElmer for serological test to identify COVID-19 antibodies
On May 5, 2020, PerkinElmer announced the FDA provided Emergency Use Authorization (EUA) for EUROIMMUN’s (a PerkinElmer company)…
On May 5, 2020, PerkinElmer announced the FDA provided Emergency Use Authorization (EUA) for EUROIMMUN’s (a PerkinElmer company)…
On May 5, 2020, ACON Laboratories announced the availability of its SARS-COV-2 IgG/IgM Rapid Test. ACONメs test is…
On May 5, 2020, Medigen Vaccine Biologics (MVB) announced a global commercial license agreement with National Institutes of…
On May 5, 2020, the HonorHealth Research Institute and HonorHealth announced the successful enrollment on a novel combination…
On May 5, 2020, Organicell Regenerative Medicine announced the FDA has approved the Investigational New Drug application for…
On May 5, 2020, Tyson Foods announced resumption of limited production at its Waterloo, Iowa facility May 7….
On May 5, 2020, Innovation Pharma reported it had executed a Material Transfer Agreement (MTA) with a leading…
On May 5, 2020, Massachusetts Eye and Ear and Massachusetts General Hospital (MGH), members of Mass General Brigham,…
On May 5, 2020, LabCorp announced that its COVID-19 Immunoglobulin G (IgG) antibody test is now available for…
On May 4, 2020, the U.S. Patent and Trademark Office (USPTO) unveiled a new web-based intellectual property marketplace…
On May 4, 2020, bioMerieux announced that BioFire Diagnostics, its subsidiary specialized in syndromic infectious disease testing, has…
On May 4, 2020, Vir Biotech and Alnylam Pharma announced the selection of a development candidate for VIR-2703,…
On May 4, 2020, Anixa Biosciences and partner OntoChem, announced they had identified its first therapeutic candidate against…
On May 4, 2020, NanoViricides announced that it has signed a Confidential Disclosure Agreement with a leading pharmaceutical…
On May 4, 2020, Junshi Biosciences and Eli Lilly announced an agreement to co-develop therapeutic antibodies for the…
On May 4, 2020, Mayo Clinic was awarded a $26 million contract from the Biomedical Advanced Research and…
On May 4, 2020, Arcturus Therapeutics and Catalent announced a partnership to support the expected manufacture of Arcturusメ…
On May 3, 2020, AbCellera announced it had received a commitment of up to $175.6 million in support…
On May 1, 2020, Gilead announced the FDA granted emergency use authorization (EUA) for the investigational antiviral remdesivir…
On May 1, 2020, the FDA issued an Emergency Use Authorization (EUA) for the investigational antiviral drug remdesivir…
On May 1, 2020, a University of Southern California (USC) study suggested that temporarily suppressing the body’s immune…
On May 1, 2020, the CDC launched the National Healthcare Safety Network (NHSN) COVID-19 Module Data Dashboard showing…
On May 1, 2020, the U.S. Dept. of Veterans Affairs (VA) announced participation in a series of clinical…
On May 1, 2020, the CDC launched the SARS-CoV-2 Sequencing for Public Health Emergency Response, Epidemiology and Surveillance…
On May 1, 2020, Moderna and Lonza announced a 10-year strategic collaboration agreement to enable larger scale manufacture…
On May 1, 2020, CHF Solutions announced that it has shipped Aquadex product to a specialty care center…
On May 1, 2020, people with cancer who develop COVID-19 are much more likely to die from the…
On May 1, 2020, Athersys and University Hospitals Cleveland Medical Center (UH Cleveland) announced that UH Cleveland is…
On May 1, 2020, XBiotech announced that human immune donors had been identified that can support the Company’s…
On Apr. 30, 2020, BioSig Technologies announced that an article titled, “The IMPDH inhibitor merimepodib provided in combination…